secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001213900-25-056209
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics upsizes ATM offering from $2.08M to $4.23M, adding $2.15M in new shares
--------------------------------------------------------------------------------

- Maximum aggregate offering price increased from $2,076,000 to $4,227,000 under November 2024 Sales Agreement with H.C. Wainwright.
- Current Prospectus Supplement filed June 20, 2025, registering an additional $2,151,000 of common stock.
- Approximately $2,075,688 in shares already sold under the prior ATM limit, nearly exhausting previous capacity.
- Proceeds intended for general corporate purposes; dilution impact on existing shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025056209/0001213900-25-056209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025056209/ea0246257-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-056209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer